ENOS gene polymorphism association with retinopathy in type 1 diabetes

Ophthalmic Genetics

Volumn 31, Issue 3, 2010, Pages 103-107

  Bazzaz, Javad Tavakkoly ^a,b   Amoli, Mahsa M ^a   Pravica, Vera ^c   Chandrasecaran, Ramesh ^d   Boulton, Andrew J ^d   Larijani, Bagher ^a   Hutchinson, Ian V ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diabetic retinopathy; E.nos; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; CAUCASIAN; CROSS-SECTIONAL STUDY; GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GREAT BRITAIN; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77955545704     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.482553     Document Type: Article

References (24)

1. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242
2. Haluzik M, Nedvidkova J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiological Research 2000;49 Suppl 1:S37-S42.
3. Johannesen J, Pie A, Pociot F, et al. Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. Journal of Clinical Endocrinology & Metabolism 2001;86:2792-2796
4. Choi KC, Lee SC, Kim SW, et al. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocininduced diabetic rats. Korean Journal of Internal Medicine 1999;14:32-41.
5. Jude EB, Boulton AJ, Ferguson MW, et al. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia, 1999; 42:748-757
6. Zochodne DW, Verge VM, Cheng C, et al. Nitric oxide synthase activity and expression in experimental diabetic neuropathy. Journal of Neuropathology & Experimental Neurology, 2000;59:798-807.
7. Shimizu T, Onuma T, Kawamori R, et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Research and Clinical Practice 2002;58:179-185
8. Taverna MJ, Sola A, Guyot-Argenton C, et al. eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabetic Medicine 2002;19:240-245
9. Spinas GA, Laffranchi R, Francoys I, et al. The early phase of glucose-stimulated insulin secretion requires nitric oxide. Diabetologia 1998;41:292-299
10. Laffranchi R, Gogvadze V, Richter C, et al. Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria. Biochemical and Biophysical Research Communications 1995; 217: 584-591
11. Tsurumi Y, Murohara T, Krasinski K, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine 1997;3:879-886
12. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Annals of the New York Academy of Science 1997;811:60-67
13. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Molecular Genetics and Metabolism 2000;70:241-251
14. Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. Journal of Biological Chemistry 1993;268:17478-17488
15. Nadaud S, Bonnardeaux A, Lathrop M, et al. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochemical and Biophysical Research Communications 1994:198:1027-1033
16. Karantzoulis-Fegaras F, Antoniou H, Lai SL, et al. Characterization of the human endothelial nitric-oxide synthase promoter. Journal of Biological Chemistry 1999;274: 3076-3093
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997 Jul; 20(7):1183-1197
18. Ohtoshi K, Yamasaki Y, Gorogawa S, et al. Assosciation of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 2002;45:1594-1601
19. Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786-?C mutation assosciated with coronary spastic angina. Hum Mol Genet 2000;9:2629-2637
20. Baron AD, Steinberg H, Brechtel G, et al. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. American Journal of Physiology 1994; 266:E248-E253.
21. Yoshimura M, Nakayama M, Shimasaki Y, et al. A T-786-? C mutation in the 5?-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. American Journal of Cardiology 2000;85,710-714
22. Taverna MJ, Sola A, Guyot-Argenton C, et al. (2002). Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 2002;45:436-442 (Pubitemid 34267367)
23. Zanchi A, Moczulski DK, Hanna LS, et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000;57:405-413
24. Asakimori Y, Yorioka N, Taniguchi Y, et al. (1786) C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 2002;91:747-751